← back to search

Smitha Suravaram

AbbVie (United States) · US
Area of research
Epidemiology · Genetics
Research interest
Research focused on Ulcerative colitis and Interim, with related work in Psoriatic arthritis, Atopic dermatitis, Term (time). Notable publications include 'Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension...', 'Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and...', and 'Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis'.
h-index
citations
39
works
3
NIH funding
primary concept
email

Recent publications

Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
˜The œLancet. Gastroenterology & hepatology 2025cited by 15position: middledoi
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Advances in Therapy 2025cited by 12position: middledoi
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis
JAMA Dermatology 2024cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Remo Panaccione · Nutrition-Génétique et Exposition aux Risques Environnementaux2 papers (2025–2025)Hannah Palac · AbbVie (United States)2 papers (2025–2025)Alan D. Irvine · Trinity College Dublin2 papers (2024–2025)Ziqian Geng · AbbVie (United States)1 papers (2025–2025)Sharanya Ford · AbbVie (United States)1 papers (2025–2025)Hiroshi Nakase · Sapporo Medical University1 papers (2025–2025)Kevin Winthrop · Ohio University1 papers (2025–2025)Gweneth Levy · AbbVie (United States)1 papers (2025–2025)Eric L. Simpson · Eli Lilly (United States)1 papers (2024–2024)John Su · University of California, Berkeley1 papers (2024–2024)Xiaofei Hu · AbbVie (United States)1 papers (2024–2024)Séverine Vermeire · Europe Hospitals1 papers (2025–2025)Amy S. Paller · Northwestern University1 papers (2024–2024)Henrique D. Teixeira · AbbVie (United States)1 papers (2024–2024)Dolly Sharma · Amity University1 papers (2025–2025)Valencia P. Remple · AbbVie (United States)1 papers (2025–2025)Emma Guttman‐Yassky · Eli Lilly (United States)1 papers (2025–2025)Andrew M. Platt · AbbVie (United States)1 papers (2024–2024)Michelle Kujawski · AbbVie (United States)1 papers (2025–2025) · 1 papers (2025–2025)